Narsoplimab Treatment for Recurrent IgA Nephropathy Stabilized eGFR and Proteinuria

被引：0
|
作者：
Storrar, Joshua [1 ]
Rainone, Francesco [1 ]
Middleton, Rachel [1 ]
Barratt, Jonathan [2 ]
机构：
[1] Northern Care Alliance NHS Fdn Trust, Salford, Lancs, England
[2] Leicester Gen Hosp, Leicester, Leics, England
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2022年 / 33卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
TH-PO521
引用
收藏
页码：195 / 195
页数：1
相关论文
共 50 条
  • [21] Seasonal proteinuria changes in IgA nephropathy patients after proteinuria remission
    Inagaki, Koji
    Yasuda, Yoshinari
    Ando, Masahiko
    Kaihan, Ahmad Baseer
    Hachiya, Asaka
    Ozeki, Takaya
    Hishida, Manabu
    Imaizumi, Takahiro
    Katsuno, Takayuki
    Kato, Sawako
    Tsuboi, Naotake
    Maruyama, Shoichi
    PLOS ONE, 2017, 12 (11):
  • [22] Long-Term Phase 2 Efficacy of the MASP-2 Inhibitor Narsoplimab for Treatment of Severe IgA Nephropathy
    Lafayette, Richard A.
    Carroll, Kevin
    Barratt, Jonathan
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : B10 - B10
  • [23] Evaluation of appropriate treatment for IgA nephropathy with mild proteinuria and normal renal function
    Ogura, Shota
    Moriyama, Takahito
    Miyabe, Yoei
    Karasawa, Kazunori
    Nitta, Kosaku
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2021, 25 (10) : 1103 - 1110
  • [24] ESTIMATING DELAY IN TIME TO ESKD FOR TREATMENT EFFECTS ON PROTEINURIA IN IGA NEPHROPATHY AND FSGS
    Carroll, Kevin
    Conley, Leah
    Mercer, Alex
    Saleem, Moin A.
    Barratt, Jonathan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [25] Evaluation of appropriate treatment for IgA nephropathy with mild proteinuria and normal renal function
    Shota Ogura
    Takahito Moriyama
    Yoei Miyabe
    Kazunori Karasawa
    Kosaku Nitta
    Clinical and Experimental Nephrology, 2021, 25 : 1103 - 1110
  • [26] Efficacy of Valsartan or Valsartan combined with Zhengqingfengtongning in the treatment of IgA nephropathy with moderate proteinuria
    Liu, Xiaowei
    Sun, Shiren
    Li, Rong
    Liu, Hongbao
    Xu, Guoshuang
    Zhang, Peng
    EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE, 2013, 5 (04) : 308 - 312
  • [27] Corticosteroid Treatment Influences TA-Proteinuria and Renal Survival in IgA Nephropathy
    Sarcina, Cristina
    Tinelli, Carmine
    Ferrario, Francesca
    Visciano, Bianca
    Pani, Antonello
    De Silvestri, Annalisa
    De Simone, Ilaria
    Del Vecchio, Lucia
    Terraneo, Veronica
    Furiani, Silvia
    Santagostino, Gaia
    Corghi, Enzo
    Pozzi, Claudio
    PLOS ONE, 2016, 11 (07):
  • [28] THE TREATMENT EFFECT OF RAS BLOCKADE ON PROTEINURIA IN IGA NEPHROPATHY PATIENTS AS A SURROGATE FOR RENAL EVENTS AND DECLINE IN EGFR: AN ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Mercer, Alex
    Carroll, Kevin
    Conley, Leah
    Barratt, Jonathan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [29] Implications of Proteinuria Remission on Estimated Glomerular Filtration Rate (eGFR) Trajectory in Patients with IgA Nephropathy in the PROTECT Trial
    Heerspink, Hiddo Jan L.
    Tesar, Vladimir
    Komers, Radko
    Hendry, Bruce M.
    Preciado, Priscila
    Murphy, Edward
    Rovin, Brad H.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [30] IgA nephropathy in children with minimal proteinuria: to biopsy or not to biopsy?
    Cambier, Alexandra
    Roy, Jean-Philippe
    Dossier, Claire
    Patey, Natacha
    Rabant, Marion
    Boyer, Olivia
    Delbet, Jean Daniel
    Lapeyraque, Anne-Laure
    Hogan, Julien
    PEDIATRIC NEPHROLOGY, 2024, 39 (03) : 781 - 787
12345